Claims Analysis
Total Claims: 19
Claim 1
Independent Claim
613 words
A compound of the formula ##STR39## or a pharmaceutically acceptable salt thereof wherein: R 1 is a cycloalkyl or polycycloalkyl hydrocarbon of from three to twelve carbon atoms with from zero to four substituents each independently selected from the group consisting of a straight or branched alkyl of from one to about six carbon atoms, halogen, CN, OR*, SR*, CO 2 R*, CF 3 , NR 5 R 6 , and --(CH 2 ) n OR 5 wherein R* is hydrogen, straight or branched alkyl of from one to six carbon atoms, --(CH 2 ) n Ar, --COAr, --(CH 2 ) n OCOAr, or --(CH 2 ) n NR 5 COAr and R* may also independently be R** as defined below, and R** must be present once in formula I, and R** is attached to formula I through a metabolically labile bond, R 5 and R 6 are each independently hydrogen or alkyl of from one to six carbon atoms and n is an integer from zero to six; and R** is --(CH 2 ) n NR 5 R 6 , --(CH 2 ) n --B--D* wherein D* is O--COR*, CO 2 Ar 2 , (CH 2 ) n Ar 2 , OCOAr 2 , NR 5 COAr 2 , COAr 2 , CO 2 CH(R)--CO 2 R*, CO 2 --(CH 2 ) n OCOR* where Ar 2 is independently taken from Ar, where m is as defined below, CONHCH(R)CO 2 R* where R is a side chain of aspartic or glutamic acid, R is hydrogen only when B is not a bond, --CO 2 CH 2 CH 2 N + (R*) 3 X 1- when X 1- is a pharmaceutically acceptable counter anion, A is --(CH 2 ) n CO--, --SO 2 --, --S(═O)--, --NHCO--, --(CH 2 ) n --C(═O)--, ##STR40## --O--(CH 2 ) n CO-- or --HC═CHCO-- wherein n is an integer from zero to six; R 2 is CH 3 ; R 3 and R 4 are each independently selected from hydrogen, R 2 and --(CH 2 ) n , --B--D wherein: n' is an integer of from zero to three; B is a bond, --OCO(CH 2 ) n --, --O(CH 2 ) n --, --NHCO(CH 2 ) n --, --CONH(CH 2 ) n --, --NHCOCH═CH--, --COO(CH 2 ) n --, --CO(CH 2 ) n --, --S--(CH 2 ) n --, --S(═)--(CH 2 ) n --, --SO 2 --(CH 2 ) n --, --NHSO 2 --(CH 2 ) n --, --SO 2 NH--(CH 2 ) n --, ##STR41## wherein R 7 and R 8 are each independently selected from hydrogen and R 2 or together form a ring (CH 2 ) m wherein m is an integer of from 1 to 5 and n is as defined above; D is hydrogen, --COOR*, --CH 2 NR 5 R*, --CHR 2 NR 5 R*, --CH 2 OR*, --CHR 2 OR*, --CH 2 SR*, --CHR 2 SR*, --CONR 5 R 6 , --CONR 5 R*, an acid replacement selected from ##STR42## wherein R*, R 2 , R 5 , and R 6 are as defined above; R 9 is hydrogen or a straight or branched alkyl of from one to six carbon atoms, --(CH 2 ) n CO 2 R*, --(CH 2 ) n NR 5 R*, wherein n, R * , and R 5 are as defined above or taken from R 3 ; R 12 and R 13 are each independently hydrogen or are each independently taken with R 3 and R 4 , respectively, to form a moiety doubly bonded to the carbon atom; and Ar is a mono- or polycyclic unsubstituted or substituted carbo- aromatic or carbo- hydroaromatic moiety.
Claim 2
Dependent Claim
613 words
A compound of the formula ##STR39## or a pharmaceutically acceptable salt thereof wherein: R 1 is a cycloalkyl or polycycloalkyl hydrocarbon of from three to twelve carbon atoms with from zero to four substituents each independently selected from the group consisting of a straight or branched alkyl of from one to about six carbon atoms, halogen, CN, OR*, SR*, CO 2 R*, CF 3 , NR 5 R 6 , and --(CH 2 ) n OR 5 wherein R* is hydrogen, straight or branched alkyl of from one to six carbon atoms, --(CH 2 ) n Ar, --COAr, --(CH 2 ) n OCOAr, or --(CH 2 ) n NR 5 COAr and R* may also independently be R** as defined below, and R** must be present once in formula I, and R** is attached to formula I through a metabolically labile bond, R 5 and R 6 are each independently hydrogen or alkyl of from one to six carbon atoms and n is an integer from zero to six; and R** is --(CH 2 ) n NR 5 R 6 , --(CH 2 ) n --B--D* wherein D* is O--COR*, CO 2 Ar 2 , (CH 2 ) n Ar 2 , OCOAr 2 , NR 5 COAr 2 , COAr 2 , CO 2 CH(R)--CO 2 R*, CO 2 --(CH 2 ) n OCOR* where Ar 2 is independently taken from Ar, where m is as defined below, CONHCH(R)CO 2 R* where R is a side chain of aspartic or glutamic acid, R is hydrogen only when B is not a bond, --CO 2 CH 2 CH 2 N + (R*) 3 X 1- when X 1- is a pharmaceutically acceptable counter anion, A is --(CH 2 ) n CO--, --SO 2 --, --S(═O)--, --NHCO--, --(CH 2 ) n --C(═O)--, ##STR40## --O--(CH 2 ) n CO-- or --HC═CHCO-- wherein n is an integer from zero to six; R 2 is CH 3 ; R 3 and R 4 are each independently selected from hydrogen, R 2 and --(CH 2 ) n , --B--D wherein: n' is an integer of from zero to three; B is a bond, --OCO(CH 2 ) n --, --O(CH 2 ) n --, --NHCO(CH 2 ) n --, --CONH(CH 2 ) n --, --NHCOCH═CH--, --COO(CH 2 ) n --, --CO(CH 2 ) n --, --S--(CH 2 ) n --, --S(═)--(CH 2 ) n --, --SO 2 --(CH 2 ) n --, --NHSO 2 --(CH 2 ) n --, --SO 2 NH--(CH 2 ) n --, ##STR41## wherein R 7 and R 8 are each independently selected from hydrogen and R 2 or together form a ring (CH 2 ) m wherein m is an integer of from 1 to 5 and n is as defined above; D is hydrogen, --COOR*, --CH 2 NR 5 R*, --CHR 2 NR 5 R*, --CH 2 OR*, --CHR 2 OR*, --CH 2 SR*, --CHR 2 SR*, --CONR 5 R 6 , --CONR 5 R*, an acid replacement selected from ##STR42## wherein R*, R 2 , R 5 , and R 6 are as defined above; R 9 is hydrogen or a straight or branched alkyl of from one to six carbon atoms, --(CH 2 ) n CO 2 R*, --(CH 2 ) n NR 5 R*, wherein n, R * , and R 5 are as defined above or taken from R 3 ; R 12 and R 13 are each independently hydrogen or are each independently taken with R 3 and R 4 , respectively, to form a moiety doubly bonded to the carbon atom; and Ar is a mono- or polycyclic unsubstituted or substituted carbo- aromatic or carbo- hydroaromatic moiety.
Claim 3
Dependent Claim
20 words
A compound according to claim 1 wherein the cycloalkyl or polycycloalkyl has from about six to about ten carbon atoms.
Claim 4
Dependent Claim
27 words
A compound according to claim 1 wherein each substituent on the cycloalkyl or polycycloalkyl is independently R*, F, Cl, Br, OR*, NR 5 R*, CF 3 .
Claim 5
Dependent Claim
83 words
A compound according to claim 1 wherein the polycycloalkyl is selected from the group consisting of ##STR43## wherein W, X, Y, and Z are each independently hydrogen, a straight or branched alkyl of from one to six carbon atoms, CF 3 , NR 5 R 6 , --(CH 2 ) n CO 2 R*, CN, F, Cl, Br, OR*, SR*, wherein R*, R 5 and R 6 are as defined in claim 1 and n is an integer of from 1 to 3.
Claim 6
Dependent Claim
20 words
A compound according to claim 1 wherein A is --NHCO--, OC(═O)--, --SO 2 --, --S(═O)--, --SCO-- or --CH 2 CO--.
Claim 7
Dependent Claim
33 words
A compound according to claim 1 wherein Ar is an unsubstituted or substituted phenyl whose substituents are each independently selected from hydrogen, fluorine, chlorine, bromine, iodine, methyl, methoxy, trifluoromethyl, nitro, --NHCOCH2COOH, and --CH2CH2CO2H.
Claim 8
Dependent Claim
68 words
A compound according to claim 1 wherein: R 1 is 2-adamantyl or 1-(S)-2-endobornyl; A is --NHCO--, --OCO--, --SO 2 --, --S(═O)-- or --CH 2 CO--; R 2 is --CH 3 , --CH 2 CO 2 H or --CH 2 C.tbd.CH; R 3 is --(CH 2 ) n , --B--D or H; R 4 is --(CH 2 ) n , --B--D or H; R 9 is hydrogen or methyl.
Claim 9
Dependent Claim
75 words
A compound according to claim 1 wherein: R 1 is 2adamantyl or 1-(S)-2-endobornyl; A is --OC(═O)--; R 2 is --CH 3 ; R 3 is H, CH 2 OR*, CH 2 OCOCH 2 CH 2 CO 2 R*, CH 2 OCOCH═CHCO 2 R*, CH 2 NHCOCH 2 CH 2 CO 2 R*, or CH 2 NHCOCH═CHCO 2 R*, R 4 is H, --NHCOCH 2 CH 2 CO 2 R*([D] configuration) or NHCOCH═CHCO 2 R*([D] configuration).
Claim 10
Dependent Claim
16 words
A compound according to claim 1 named butanoic acid, 4-[[2-[[3-(1H-indol-3-yl)-2-methyl-1-oxo-2-[[(tricyclo[3.3.1.1 3 ,7 ]dec-2-yloxy)carbonyl]amino]propyl]amino]-1-phenylethyl]amino]-4-oxo, (2,2-dimethyl-1-oxopropoxy)methyl ester [R-(R*,R*)]--.
Claim 11
Dependent Claim
12 words
A compound named butanoic acid, 4-[[2-[[3-(1H-indol-3-yl)-2-methyl-1-oxo-2-[[(tricyclo[3.3.1.1 3 ,7 ]dec-2-yloxy)carbonyl]amino]propyl]amino]ethyl]amino]-4-oxo-, chloromethyl ester, [R-(R*,R*)]--.
Claim 12
Dependent Claim
12 words
A compound named butanoic acid, 4-[[2-[[3-(1H-indol-3-yl)-2-methyl-1-oxo-2-[[(tricyclo[3.3.1.1 3 ,7 ]dec-2-yloxy)carbonyl]amino]propyl]amino]ethyl]amino]-4-oxo-, chloromethyl ester, [R-(R*,R*)]--.
Claim 13
Dependent Claim
15 words
A compound according to claim 1 named Pentanedioic acid, [4-[[2-[[3-(1H-indol-3-yl)-2-methyl-1-oxo-2-[[tricyclo[3.3.1.1 3 ,7 ]dec-2-yloxy)carbonyl]amino]propyl]amino]-1-phenylethyl]amino]-1,4-dioxobutoxy]methyl ester, [R-(R*,R*)]--.
Claim 14
Dependent Claim
15 words
A compound according to claim 1 named butanoic acid, 4-[[2-[[3-(1H-indol-3-yl)-2-methyl-1-oxo-2-[[tricyclo[3.3.1.1 3 ,7 ]dec-2-yloxy)carbonyl]amino]propyl]amino]-1-phenylethyl]amino]-4-oxo-2,3-dihydro-1H-inden-5-yl ester, [R-(R*,R*)]--.
Claim 15
Dependent Claim
16 words
A compound according to claim 1 named butanoic acid, 4-[[2-[[3-(1H-indol-3-yl)-2-methyl-1-oxo-2-[[(tricyclo[3.3.1.1 3 ,7 ]dec-2-yloxy)carbonyl]amino]propyl]amino]-1-phenylethyl]amino]-4-oxo-, 2-(diethylamino)ethyl ester [R-(R*,R*)]--.
Claim 16
Dependent Claim
13 words
A compound according to claim 1 named L-Aspartic acid, N-[N-[α-methyl-N-[(tricyclo[3.3.1.1 3 ,7 ]-dec-2-yloxy)carbonyl]-D-tryptophyl]-L-phenylalanyl]--.
Claim 17
Dependent Claim
13 words
A compound according to claim 1 named L-Glutamic acid, N-[N-[α-methyl-N-[(tricyclo[3.3.1.1 3 ,7 ]-dec-2-yloxy)carbonyl]-D-tryptophyl]-L-phenylalanyl]--.
Claim 18
Dependent Claim
15 words
A compound according to claim 1 named L-Glutamic acid, N-[N-[α-methyl-N-[(tricyclo[3.3.1.1 3 ,7 ]-dec-2-yloxy)carbonyl]-D-tryptophyl]-L-phenylalanyl]--, dimethyl ester.
Claim 19
Dependent Claim
68 words
A pharmaceutical composition comprising an amount of a compound according to claim 1 effective to treat gastrointestinal ulcers, psychotic behavior, to block the reaction caused by withdrawal from drug or alcohol use, to potentiate the effects of morphine or other opioids in treating pain, to suppress appetite, to reduce gastric acid secretion, to reduce anxiety, to treat and/or prevent panic in a mammal, and a pharmaceutically acceptable carrier.